McKesson Corporation (LON:0JZU)
London · Delayed Price · Currency is GBP · Price in USD 759.85
+16.91 (2.28%)
At close: Sep 24, 2025
McKesson Market Cap
McKesson has a market cap or net worth of 68.23 billion as of September 24, 2025. Its market cap has increased by 35.00% in one year.
Market Cap
68.23B
Enterprise Value
74.62B
Revenue
275.61B
Ranking
n/a
PE Ratio
29.54
Stock Price
759.85
Market Cap Chart
Since November 10, 1994, McKesson's market cap has increased from 904.45M to 68.23B, an increase of 7,443.72%. That is a compound annual growth rate of 15.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2025 | 70.33B | 21.71% |
| Dec 31, 2024 | 57.79B | 19.48% |
| Dec 29, 2023 | 48.37B | 9.56% |
| Dec 30, 2022 | 44.14B | 57.50% |
| Dec 31, 2021 | 28.03B | 37.03% |
| Dec 31, 2020 | 20.45B | 8.69% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 175.29B |
| GSK plc | 60.24B |
| Haleon | 30.25B |
| Smith & Nephew | 11.86B |
| ConvaTec Group | 4.69B |
| Hikma Pharmaceuticals | 3.58B |
| HUTCHMED (China) | 2.19B |
| Genus | 1.62B |